Sankyo Co. News Monitoring
-
Published on Feb 27, 2021Source: Reuters - Neutral
-
Published on Feb 21, 2021
Takeda and Daiichi Sankyo to begin COVID-19 vaccine trials in Japan
Source: Seeking Alpha - Neutral -
Published on Jan 20, 2021
AstraZeneca And Daiichi Sankyo's Enhertu Approved In EU For Breast Cancer
AstraZeneca Plc. (AZN.L,AZN) and Daiichi Sankyo Company Limited (DSKYF.PK) said that the European Union has conditionally approved Enhertu or trastuzumab deruxtecan as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2- …
Source: RTTNews - Neutral -
Published on Jan 20, 2021
AstraZeneca, Daiichi Sankyo breast cancer drug wins conditional approval in EU
StockMarketWire.com - Drug companies AstraZeneca and Daiichi Sankyo said their breast cancer drug was granted conditional approval in the European Union. Enhertu was granted approval as a monotherapy for the treatment of adult patients with HER2-positive …
Source: Stock Market Wire - Neutral -
Published on Jan 18, 2021
AstraZeneca, Daiichi Sankyo: Enhertu Gets US Approval For HER2-positive Advanced Gastric Cancer
AstraZeneca plc (AZN.L,AZN) and Daiichi Sankyo Co. Limited (DSKYF.PK) announced Monday that Enhertu (trastuzumab deruxtecan) has been approved in the US for the treatment of adult patients with previously treated HER2-positive advanced gastric cancer. The …
Source: RTTNews - Neutral -
Published on Jan 18, 2021
ViGeneron announces research collaboration with Daiichi Sankyo to evaluate vgAAV for novel ophthalmic gene therapy
MUNICH, Germany, Jan. 18, 2021 (GLOBE NEWSWIRE) -- ViGeneron GmbH, a gene therapy company, today announced a research collaboration to utilize its novel engineered adeno-associated virus (vgAAV) vectors with Daiichi Sankyo Company, Limited (“Daiichi Sankyo …
Distribution channels: Healthcare & Pharmaceuticals Industry -
Published on Jan 18, 2021
AstraZeneca, Daiichi Sankyo gastric cancer drug wins approval in US
StockMarketWire.com - Pharmaceutical giants AstraZeneca and Daiichi Sankyo said their gastric cancer drug had been approved in the US. The approval of enhertu by the Food and Drug Administration was based on positive results froma Destiny-Gastric01 phase- …
Source: Stock Market Wire - Neutral -
Published on Dec 29, 2020
Daiichi Sankyo: Plenty To Like, Except For The Price
Source: Seeking Alpha - Neutral -
Published on Dec 16, 2020
Daiichi Sankyo, AstraZeneca initiate TROPION─Lung05 phase 2 trial of datopotamab deruxtecan in patients with advanced/...
Daiichi Sankyo Company, Limited and AstraZeneca announced the initiation of TROPION-Lung05, a global phase 2 trial of datopotamab deruxtecan (Dato-DXd; DS-1062), a TROP2 directed antibody drug conjugate (ADC), in patients with advanced or metastatic non- …
Source: Pharmabiz.com - Neutral -
Published on Dec 16, 2020
Daiichi Sankyo seeks Japanese expanded indication approval for antiplatelet agent, prasugrel HCl for prevention of ...
Daiichi Sankyo Company, Limited announced that a supplemental application for the antiplatelet agent, prasugrel hydrochloride, was filed in Japan to expand the indication for prevention of recurrence of ischemic stroke as a partial change in items of the …
Source: Pharmabiz.com - Neutral -
Published on Dec 16, 2020
Daiichi Sankyo, Esperion Report Swissmedic Approval For NILEMDO & NUSTENDI
Daiichi Sankyo Europe GmbH (DSKYF.PK) and Esperion Therapeutics (ESPR) announced Swissmedic approval for NILEMDO tablet and NUSTENDI tablet, for people with high low-density lipoprotein cholesterol in Switzerland. NILEMDO (bempedoic acid) is the first oral …
Source: RTTNews - Neutral -
Published on Dec 15, 2020
EMA committee recommends conditional marketing approval for Daiichi Sankyo & AstraZeneca's trastuzumab deruxtecan to ...
Daiichi Sankyo Company, Limited and AstraZeneca’s trastuzumab deruxtecan has been recommended for conditional marketing authorization in the European Union (EU) as monotherapy for the treatment of adult patients with unresectable or metastatic HER2 …
Source: Pharmabiz.com - Neutral -
Published on Dec 10, 2020
AstraZeneca, Daiichi Sankyo: ENHERTU Demonstrated Durable Responses In Phase II Trial
AstraZeneca plc (AZN.L,AZN) and Daiichi Sankyo Co. Limited (DSKYF.PK) said Thursday that updated results from the positive DESTINY-Breast01 Phase II trial showed ENHERTU (fam-trastuzumab deruxtecan-nxki) continued to demonstrate impressive efficacy and …
Source: RTTNews - Neutral -
Published on Dec 16, 2020
Daiichi Sankyo/Esperion's cholesterol med approved in Switzerland
Source: Seeking Alpha - Neutral -
Published on Dec 10, 2020
AZN/Daiichi Sankyo' Enhertu scores ‘impressive’ new data in HER2 breast cancer study
Source: Seeking Alpha - Neutral -
Published on Nov 11, 2020
Global Impact of Covid-19 on Influenza Drugs And Vaccines Market to Witness Promising Growth Opportunities During 2020-...
The MarketWatch News Department was not involved in the creation of this content. Nov 11, 2020 (Market Insight Reports) -- Reports and Data has added a new informative research report titled Global Influenza Drugs And Vaccines Market report to its ever- …
Source: MarketWatch - Neutral -
Published on Nov 3, 2020
Daiichi Sankyo Co Ltd (DSKYF) CEO Sunao Manabe on Q2 2021 Results - Earnings Call Transcript
Daiichi Sankyo Co Ltd (OTCPK:DSKYF) Q2 2021 Earnings Conference Call November 2, 2020 2:30 AM ET Company Participants Junichi Onuma - VP, Corporate Communications Department Sunao Manabe - President & Group CEO Wataru Takasaki - Executive Officer & …
Source: Seeking Alpha - Neutral -
Published on Oct 28, 2020
AstraZeneca and Daiichi Sankyo's Enhertu granted FDA Priority Review for treatment of HER2-positive metastatic gastric ...
Biopharmaceutical company AstraZeneca (STO:AZN) (LON:AZN) and Japan's Daiichi Sankyo Company Limited reported on Wednesday that Enhertu (trastuzumab deruxtecan) has been granted Priority Review in the United States for the treatment of HER2-positive …
Source: M2 - Uncategorized -
Published on Oct 22, 2020
Daiichi Sankyo Initiates Phase 1 Trial with Immuno-Oncology Therapy DS-1055 Targeting GARP on Activated Regulatory T ...
TOKYO, MUNICH & BASKING RIDGE, N.J.--(BUSINESS WIRE)--Oct 22, 2020-- Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced today that the first patient has been dosed in a first-in-human global phase 1 study evaluating DS-1055, a GARP …
Source: Odessa American - Texas - Neutral
Featured Releases
-
Published on April 9, 2021 - 13:32 GMT
BioSig Invited to Join Alliance for Artificial Intelligence in Healthcare (AAIH)
Westport, CT, April 09, 2021 (GLOBE NEWSWIRE) -- Global leaders, including Amazon, Bayer, and GE Healthcare, joined the AAIH to date to collaborate on developing novel solutions to improve the quality of care and reduce failure rates The Company recently …
Distribution channels: -
Published on April 9, 2021 - 13:20 GMT
Healthcare Workers Call On California Voters to Support Gov. Newsom and Get Ready to Vote No on the Republican Recall ...
Oakland, Calif., April 09, 2021 (GLOBE NEWSWIRE) -- Healthcare workers representing SEIU-UHW’s 100,000 members voted overwhelmingly to oppose the recall of Gov. Gavin Newsom, calling him a proven healthcare champion and citing his long record of supporting …
Distribution channels: Media, Advertising & PR ...
-
Published on April 9, 2021 - 13:24 GMT
Vericel to Present at the 20th Annual Needham Virtual Healthcare Conference on Thursday, April 15, 2021
CAMBRIDGE, Mass., April 09, 2021 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, President and CEO, will present the latest …
Distribution channels: -
Published on April 9, 2021 - 13:00 GMT
Healthcare Collaborative Robots Market - Forecast to 2026
Brooklyn, New York, April 09, 2021 (GLOBE NEWSWIRE) -- According to new market research published by Global Market Estimates, the Healthcare Collaborative Robots Market will grow with a high CAGR during the forecast period [2021 to 2026]. Healthcare …
Distribution channels:
-
Published on April 9, 2021 - 13:00 GMT
Acadia Healthcare Announces Date for First Quarter 2021 Earnings Release
FRANKLIN, Tenn., April 09, 2021 (GLOBE NEWSWIRE) -- Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that it will release its first quarter 2021 results on Thursday, April 29, 2021, after the close of the market. Acadia will conduct a …
Distribution channels: -
Published on April 9, 2021 - 11:00 GMT
COMPASS Pathways plc to participate in 20th Annual Needham Virtual Healthcare Conference
London, UK, April 09, 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that George Goldsmith, Chairman, CEO …
Distribution channels: -
Published on April 9, 2021 - 11:00 GMT
eSight 4 Recognized as the Best Wearable/Healthcare Hardware/Software of 2021 by Tech Ascension Awards
TORONTO, April 09, 2021 (GLOBE NEWSWIRE) -- Leading vision-enhancement platform, eSight, today announces eSight 4 has been recognized as the Best Wearable/Healthcare Hardware/Software of 2021 by the Tech Ascension Awards, which honors companies …
Distribution channels: -
Published on April 8, 2021 - 15:13 GMT
Storyvine Launches Home Healthcare Kit, Continues Expansion of Self-Service Video Platform
New Pre-Built Video Templates Developed for Home Healthcare Industry to Attract Talent and Promote Agencies through Video Marketing DENVER, COLORADO, USA, April 8, 2021 /EINPresswire.com/ -- Storyvine, Inc., a leading pro user-generated video …
Distribution channels: Healthcare & Pharmaceuticals Industry ...
Online News Monitoring Made Simple
Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.
News by Country & by Industry
Track news across more than 5,000 sources by country or industry or search our real-time news index.
News Alerts & News Feeds
News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.
Submit News
Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.
World Media Directory
This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 04/09/2021

Healthcare & Pharmaceuticals Industry Press Releases
-
Published on April 11, 2021 - 17:32 GMT
Koios Medical Announces FDA Breakthrough Device Designation for Early Cancer Detection AI Software.
Koios Medical announced receiving Breakthrough Device designation from the USFDA for AI software to detect and diagnosis breast and thyroid cancer. NEW YORK, NY, UNITED STATES, April 11, 2021 /EINPresswire.com/ -- Koios Medical, a US developer …
Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ... -
Published on April 11, 2021 - 17:32 GMT
Zeta Pharma Launches The Novel Diabetes Medication In The Egyptian Market.
CAIRO, EGYPT, April 11, 2021 /EINPresswire.com/ -- In the presence of a group of eminent Egyptian professors of Internal medicine and endocrinology, a luxury hotel in Cairo witnessed the launch conference of “𝐄𝐦𝐩𝐚𝐜𝐨𝐳𝐚”, the latest type 2 diabetes …
Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ... -
Published on April 11, 2021 - 14:00 GMT
Coronavirus - Rwanda: COVID-19 update (10 April 2021)
Total cases: 23,343 (+83) Recovered: 21,072 (+81) | 90.2% Active cases: 1,957 In critical condition: 6 Tests: 1,214,021 (+6,928) Test positivity rate: 1.2% Vaccinated: 348,926 Deaths: 314 (+0) | 1.3%Distributed by APO Group on behalf of Ministry of Health, …
Distribution channels: Healthcare & Pharmaceuticals Industry, World & Regional -
Published on April 11, 2021 - 14:00 GMT
Coronavirus - Eswatini: COVID-19 update (10 April 2021)
Download logo Minister of Health Lizzie Nkosi's COVID-19 update on 10 April 2021: New cases: 3 Total cases: 17 373 Active cases: 35 Total recoveries: 16 645Distributed by APO Group on behalf of Ministry of Health, Government of the Kingdom of Eswatini.
Distribution channels: Healthcare & Pharmaceuticals Industry, World & Regional -
Published on April 11, 2021 - 14:00 GMT
Coronavirus - Kenya: COVID-19 update (10 April 2021)
Download logo 1,030 people have tested positive to the disease, from a sample size of 8,316 tested in 24 hours. Our positivity rate is at 12.4%. Total confirmed positive cases are now 145,184 and cumulative tests so far conducted are 1,557,704. …
Distribution channels: Healthcare & Pharmaceuticals Industry, World & Regional -
Published on April 10, 2021 - 18:01 GMT
SqlDBM to Host Hands-On Lab at WWDVC 2021
SqlDBM will host a hands-on lab session at WWDVC 2021 of their cloud-native data modeling tool SAN DIEGO, CALIFORNIA, UNITED STATES, April 10, 2021 /EINPresswire.com/ -- SqlDBM, a cloud-native database modeling tool, has announced that it will …
Distribution channels: Business & Economy, Conferences & Trade Fairs ... -
Published on April 10, 2021 - 14:48 GMT
Frontline and Immigrant Workers Receive Care Packages In 'Aid To Humanity' Events By Iglesia Ni Cristo
Essential workers in British Columbia, Canada receive appreciation and a morale boost from outreach events of global Church. VANCOUVER, BRITISH COLUMBIA, CANADA, April 10, 2021 /EINPresswire.com/ -- The Iglesia Ni Cristo (INC) or Church Of …
Distribution channels: Business & Economy, Companies ... -
Published on April 10, 2021 - 21:54 GMT
Coronavirus - Rwanda: COVID-19 update (9 April 2021)
Total cases: 23,260 (+108) Recovered: 20,991 (+121) | 90.2% Active cases: 1,955 In critical condition: 6 Tests: 1,207,093 (+6,557) Test positivity rate: 1.6% Vaccinated: 348,926 Deaths: 314 (+0) | 1.3%Distributed by APO Group on behalf of Ministry of …
Distribution channels: Healthcare & Pharmaceuticals Industry, World & Regional -
Published on April 10, 2021 - 21:54 GMT
Coronavirus - Nigeria: COVID-19 update (9 April 2021)
71 new cases of COVID-19 in Nigeria; Lagos-24 Yobe-13 Rivers-9 Akwa Ibom-6 FCT-6 Kano-6 Osun-3 Delta-2 Jigawa-1 Plateau-1 163,652 confirmed 154,073 discharged 2,059 deathsDistributed by APO Group on behalf of Nigeria Centre for Disease Control (NCDC).
Distribution channels: Healthcare & Pharmaceuticals Industry, World & Regional -
Published on April 10, 2021 - 21:54 GMT
Coronavirus - Malawi: COVID-19 update (9 April 2021)
Malawi has registered 41 new COVID-19 cases, 99 new recoveries and one new death. All new cases are locally transmitted: 13 from Thyolo, nine from Blantyre, eight from Lilongwe, two each from Dowa and Ntchisi, and one each from Balaka, Mzimba South, Neno, …
Distribution channels: Healthcare & Pharmaceuticals Industry, World & Regional -
Published on April 10, 2021 - 21:54 GMT
Coronavirus: African Union Member States reporting COVID-19 cases as of 10 April 2021, 9 am EAT
African Union Member States (55) reporting COVID-19 cases (4,330,666), deaths (115,191) and recoveries (3,888,495) by region: Central (143,411 cases; 2,315 deaths; 128,830 recoveries): Burundi (3,027; 6; 1,155), Cameroon (61,731; 919; 56,926), CAR (5,491; …
Distribution channels: Healthcare & Pharmaceuticals Industry, World & Regional -
Published on April 10, 2021 - 19:05 GMT
C4 Therapeutics Presents Preclinical Data on CFT7455, a Novel IKZF1/3 Degrader for the Treatment of Hematologic ...
– CFT7455 Demonstrated High Cereblon Binding Affinity and Rapid, Deep IKZF1/3 Degradation Enabling Activity across a Panel of Multiple Myeloma Cell Lines Including IMiD-Resistant Models – – CFT7455 Promotes Sustained Degradation of IKZF1/3 and …
Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ... -
Published on April 10, 2021 - 17:31 GMT
PMV Pharma Presents Late-Breaking Preclinical Data on Lead Product Candidate PC14586 at the American Association for ...
PC14586 selectively stabilizes the p53 Y220C mutant and restores p53 activity Robust in vivo tumor regression observed with once daily oral dosing Pharmacodynamic biomarkers of p53 activation developed for clinical trials PC14586 is being tested in a Phase …
Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ... -
Published on April 10, 2021 - 17:30 GMT
Zentalis Pharmaceuticals Announces Promising Initial Data Presented in a Late-Breaking Session at AACR on ZN-c3, its ...
ZN-c3 demonstrated single agent activity, generating Exceptional Responses in a range of heavily pre-treated solid tumors ZN-c3 was safe and well-tolerated Identified recommended Phase 2 dose for ZN-c3 to be 300 mg QD with continuous dosing Announces plan …
Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ... -
Published on April 10, 2021 - 17:09 GMT
Meticore Review: Real Customer Complaints or Weight Loss Pills That Work?
Chicago, IL, April 10, 2021 (GLOBE NEWSWIRE) -- April 2021 Update: Meticore is a worldwide phenomenon in the natural weight loss supplement industry (that's valued at over $24 billion annually in 2020) because of its morning metabolism triggering …
Distribution channels: Consumer Goods, Culture, Society & Lifestyle ... -
Published on April 10, 2021 - 16:39 GMT
BioFit Probiotic Scam Risks (What They'll Never Tell You!!!)
Detroit, MI, April 10, 2021 (GLOBE NEWSWIRE) -- BioFit is a new weight loss supplement designed to boost your metabolism by improving gut health and balancing your metabolic hormones. It was developed by Christina Miller, a former housewife who dealt with …
Distribution channels: Consumer Goods, Culture, Society & Lifestyle ... -
Published on April 10, 2021 - 15:16 GMT
Coronavirus - Eswatini: COVID-19 update (9 April 2021)
Download logo Minister of Health Lizzie Nkosi's COVID-19 update on 9 April 2021: New cases: 3 Total cases: 17 370 Active cases: 56 New recoveries: 3 Total recoveries: 16 642Distributed by APO Group on behalf of Ministry of Health, Government of the …
Distribution channels: Healthcare & Pharmaceuticals Industry, World & Regional -
Published on April 10, 2021 - 15:15 GMT
Coronavirus - Kenya: COVID-19 update (9 April 2021)
Download logo 1,091 people have tested positive to the disease, from a sample size of 7,300. Our positivity rate is at 14.9 %. Total confirmed positive cases are now 144,154. Cumulative tests so far conducted are 1,549,388. Distribution of positive cases …
Distribution channels: Healthcare & Pharmaceuticals Industry, World & Regional -
Published on April 10, 2021 - 15:15 GMT
Coronavirus - Zambia: COVID-19 update (9 April 2021)
We recorded 191 new cases out of 6,435 tests (3% positivity), 113 recoveries and 1 new death (Mhsripp).Distributed by APO Group on behalf of Zambia National Public Health Institute (ZNPHI).
Distribution channels: Healthcare & Pharmaceuticals Industry, World & Regional -
Published on April 10, 2021 - 15:15 GMT
Coronavirus - Zimbabwe: COVID-19 update (9 April 2021)
Download logo As at 09 April 2021, Zimbabwe had 37 147 confirmed cases, including 34 831 recoveries and 1 535 deaths. To date, a total of 178 237 people have been vaccinated against COVID-19.Distributed by APO Group on behalf of Ministry of Health and …
Distribution channels: Healthcare & Pharmaceuticals Industry, World & Regional
Healthcare & Pharmaceuticals Events
No event was found.

- Track news from thousands of sources
- Submit news sources for inclusion in our news tracking algorithm
- Build your own customized email newsletters
- Use of our RSS Feeds
- Includes a complimentary EIN Presswire account plus 1-free release
- Uncluttered & advertising free news pages